7-Hydroxymitragynine (7-OH)
Detailed, medically-reviewed information for 7-Hydroxymitragynine (7-OH) is being prepared.
Detailed, medically-reviewed information for 7-Hydroxymitragynine (7-OH) is being prepared. Verified chemistry is shown; effects, dosing, risks, and harm-reduction guidance are published only after clinical review.
Images
Visual references coming soon.
If it’s too intense
If an experience becomes overwhelming, the goal is to stay safe and let it pass — most difficult experiences ease as the drug wears off.
- Get to a calm, safe space with someone you trust who is sober and can stay with you.
- Cool down if you’re overheating — move somewhere cool, remove extra layers, rest. Overheating is especially a risk with stimulants and MDMA.
- Sip water to thirst — but don’t over-hydrate. Drinking large amounts of plain water (especially after MDMA) can dangerously dilute your blood sodium (hyponatremia). Electrolytes help more than volume.
- Slow your breathing — long, slow exhales help settle a racing heart and anxiety.
- A sugary drink, fruit juice, or a snack can ease shakiness and the anxiety that comes with low blood sugar.
- Do not take more, and do not add another substance to manage it. Redosing or adding something else (including a sedative like a benzodiazepine) can make things worse, not better.
With opioids, slowed or stopped breathing is the emergency — if available, give naloxone and call 911 immediately; it can be given while you wait for help.
Source: general harm-reduction guidance from SAMHSA, NIH/NIDA, and MedlinePlus, in our own words. Draft — not yet medically reviewed.
Forensic dossier
Draft · every field is source-cited or marked “Unknown — pending review”Identity
- PubChem CID
- 44301524PubChem PUG-REST ↗ · retrieved 2026-06-18
- IUPAC name
- methyl (E)-2-[(2S,3S,7aS,12bS)-3-ethyl-7a-hydroxy-8-methoxy-2,3,4,6,7,12b-hexahydro-1H-indolo[2,3-a]quinolizin-2-yl]-3-methoxyprop-2-enoatePubChem PUG-REST ↗ · retrieved 2026-06-18
- Molecular formula
- C23H30N2O5PubChem PUG-REST ↗ · retrieved 2026-06-18
- SMILES
- CC[C@@H]1CN2CC[C@]3(C(=NC4=C3C(=CC=C4)OC)[C@@H]2C[C@@H]1/C(=C\OC)/C(=O)OC)OPubChem PUG-REST ↗ · retrieved 2026-06-18
- InChIKey
- RYENLSMHLCNXJT-CYXFISRXSA-NPubChem PUG-REST ↗ · retrieved 2026-06-18
- Synonyms / aliases
- 7-oh, 7-Hydroxymitragynine, Mitragynine hydroxyindolenine, 7-hydroxy-mitragynine, 7-Hydroxy MitragyninePubChem PUG-REST + seed aliases ↗ · retrieved 2026-06-18
Composition
- Composition
- N/A — single compound (see Identity)
Physical / pill characteristics
- Dosage form
- Unknown — pending review (no Rx/OTC label; illicit — pill visuals = FIRST-PARTY submissions only, never generated or scraped)
- Route
- Unknown — pending review
- Shape
- Unknown — pending review
- Color
- Unknown — pending review
- Imprint
- Unknown — pending review
- Score
- Unknown — pending review
Scheduling & legal status
- US schedule
- Unknown — pending review
- International
- Unknown — pending review
Dosage
Pending medical reviewer
